Site,severity& Infection Type Influence On Superoxide Di

地点、严重程度

基本信息

  • 批准号:
    6683812
  • 负责人:
  • 金额:
    --
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
  • 资助国家:
    美国
  • 起止时间:
  • 项目状态:
    未结题

项目摘要

Superoxide anion production is necessary for leukocyte, vascular endothelial and other functions during infection. However, excessive production of superoxide and its reactant products has been implicated in the pathogenesis of tissue injury and organ dysfunction occurring during sepsis and septic shock. Examination of tissue samples in animal models has also suggested that depletion of endogenous antioxidants such as superoxide dismutase during sepsis may potentiate this injury. As a result, antioxidant treatments employing low molecular weight nonprotein membrane-permeable superoxide dismutase mimetics have been developed for use in sepsis and other conditions associated with increased systemic inflammation. These agents which are metal-chelated macrocyclic ligand complexes, demonstrate free radical scavenging activities similar to superoxide dismutase. M40401 and M40403 are two such agents which show novel selectivity for superoxide anion itself. Superoxide anion however may have divergent effects during sepsis. In addition to the opposing roles superoxide might have on microbial killing and secondary inflammatory tissue injury, it also has the potential to alter hemodynamic function in opposing ways. Excessive superoxide production has been implicated in the oxidation of both endogenous and exogenous catecholamines which normally cause vasoconstriction. On the other hand, superoxide anion contributes to the inactivation of nitric oxide, a potent vasodilator. As a result, the overall effects of superoxide anion on vascular tone may represent its relative contribution to the inactivation of catecholamines versus nitric oxide. These contributions may vary during sepsis dependent on its severity. In turn, the hemodynamics effects of superoxide inhibitors like M40401 may also be influenced by the underlying severity of sepsis. The present studies investigated whether the severity of infectious challenge and its associated risk of death would alter the efficacy of M40401 in a rat model of sepsis. In individual experiments, animals were randomized to be challenged with doses of intravenous E. coli designed to produce low or high control mortality rates, following which they were treated with M40401 or placebo. The results showed that the efficacy of M40401 was dependent on control mortality rates. In experiments with high control mortality rates (i.e. > median), M40401 increased survival rates and mean arterial blood pressure and decreased platelet counts. However in experiments with low control mortality rates (i.e.
超氧阴离子的产生是感染时白细胞、血管内皮等功能所必需的。然而,超氧化物及其反应产物的过量产生与脓毒症和脓毒性休克期间发生的组织损伤和器官功能障碍的发病机制有关。在动物模型中的组织样本的检查也表明,内源性抗氧化剂,如超氧化物歧化酶在脓毒症的消耗可能会加强这种损伤。因此,采用低分子量非蛋白质膜渗透性超氧化物歧化酶模拟物的抗氧化剂治疗已被开发用于败血症和与全身炎症增加相关的其他病症。这些试剂是金属螯合大环配体络合物,表现出类似于超氧化物歧化酶的自由基清除活性。M40401和M40403是两种对超氧阴离子本身具有新颖选择性的试剂。 然而,超氧阴离子在脓毒症期间可能具有不同的作用。除了超氧化物可能对微生物杀灭和继发性炎症组织损伤具有相反的作用外,它还可能以相反的方式改变血液动力学功能。过量的超氧化物产生与内源性和外源性儿茶酚胺的氧化有关,这通常会引起血管收缩。另一方面,超氧阴离子有助于一氧化氮的失活,一氧化氮是一种有效的血管扩张剂。因此,超氧阴离子对血管张力的总体影响可能代表其对儿茶酚胺与一氧化氮失活的相对贡献。这些贡献在脓毒症期间可能根据其严重程度而变化。反过来,超氧化物抑制剂如M40401的血液动力学效应也可能受到脓毒症潜在严重程度的影响。 本研究研究了感染性攻毒的严重程度及其相关死亡风险是否会改变M40401在脓毒症大鼠模型中的疗效。在单独的实验中,动物被随机分配接受静脉注射E。大肠杆菌设计,以产生低或高的控制死亡率,然后他们与M40401或安慰剂治疗。结果表明,M40401的功效取决于控制死亡率。在对照死亡率较高(即>中位数)的实验中,M40401可增加存活率和平均动脉血压,并降低血小板计数。然而,在具有低对照死亡率的实验中(即,

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Peter Q Eichacker其他文献

Peter Q Eichacker的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Peter Q Eichacker', 18)}}的其他基金

Effects of Therapeutic Recombinant Granulocyte Colony Stimulating Factor
治疗性重组粒细胞集落刺激因子的作用
  • 批准号:
    6227873
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
TYROSINE KINASE INHIBITION IN A CANINE MODEL OF S. AUREUS INFECTION
犬金黄色葡萄球菌感染模型中酪氨酸激酶的抑制
  • 批准号:
    6289408
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
TYPE OF INFECTION ON EFFECTS OF ENDOTOXIN ANALOG
感染类型对内毒素类似物的影响
  • 批准号:
    6414070
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
Influence Of Systemic Inflammation On The Effects Of Rec
全身炎症对 Rec 效果的影响
  • 批准号:
    6546515
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
Site,severity& Infection Type Influence On Superoxide Di
地点、严重程度
  • 批准号:
    6825056
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
NF-kappa B in Murine Sepsis
小鼠脓毒症中的 NF-kappa B
  • 批准号:
    7003964
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
Influence Of Site, Severity, And Type Of Infection On Ef
感染部位、严重程度和类型对 Ef 的影响
  • 批准号:
    6993911
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
Pretreatment Sublethal B. Anthracis Lethal Toxin in Rats
预处理大鼠亚致死炭疽杆菌致死毒素
  • 批准号:
    7003993
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
NF-kappa B in Murine Sepsis
小鼠脓毒症中的 NF-kappa B
  • 批准号:
    7215794
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
PA-mAb in a Rat Model of Anthrax Sepsis
PA-mAb 在炭疽脓毒症大鼠模型中的作用
  • 批准号:
    7215804
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:

相似海外基金

Development of Host induced Gene Editing (Hi-GE): a novel platform for bacterial disease control
宿主诱导基因编辑(Hi-GE)的开发:细菌性疾病控制的新平台
  • 批准号:
    10004717
  • 财政年份:
    2021
  • 资助金额:
    --
  • 项目类别:
    Collaborative R&D
Elucidation of the pathogenic mechanism of black spot bacterial disease using a comprehensive screening method
利用综合筛查方法阐明黑斑细菌性疾病的致病机制
  • 批准号:
    19K06045
  • 财政年份:
    2019
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
The relationship between malarial anaemia, neutrophil function and susceptibility to invasive bacterial disease.
疟疾贫血、中性粒细胞功能与侵袭性细菌性疾病易感性之间的关系。
  • 批准号:
    MR/P000959/2
  • 财政年份:
    2017
  • 资助金额:
    --
  • 项目类别:
    Research Grant
Redefining the role of autophagy in bacterial disease
重新定义自噬在细菌性疾病中的作用
  • 批准号:
    10519116
  • 财政年份:
    2016
  • 资助金额:
    --
  • 项目类别:
Redefining the role of autophagy in bacterial disease
重新定义自噬在细菌性疾病中的作用
  • 批准号:
    10053295
  • 财政年份:
    2016
  • 资助金额:
    --
  • 项目类别:
Redefining the role of autophagy in bacterial disease
重新定义自噬在细菌性疾病中的作用
  • 批准号:
    10764559
  • 财政年份:
    2016
  • 资助金额:
    --
  • 项目类别:
The relationship between malarial anaemia, neutrophil function and susceptibility to invasive bacterial disease.
疟疾贫血、中性粒细胞功能与侵袭性细菌性疾病易感性之间的关系。
  • 批准号:
    MR/P000959/1
  • 财政年份:
    2016
  • 资助金额:
    --
  • 项目类别:
    Research Grant
Redefining the role of autophagy in bacterial disease
重新定义自噬在细菌性疾病中的作用
  • 批准号:
    10384537
  • 财政年份:
    2016
  • 资助金额:
    --
  • 项目类别:
The treatment of bacterial disease of plants by bacteriophage coated nanoparticles
噬菌体包被纳米颗粒治疗植物细菌性疾病
  • 批准号:
    BB/K501979/1
  • 财政年份:
    2013
  • 资助金额:
    --
  • 项目类别:
    Training Grant
Identification of disease resistance loci against bacterial disease (Streptococcus iniae)in rainbow trout(Oncorhynchus mykiss)
虹鳟鱼(Oncorhynchus mykiss)细菌性病害(海豚链球菌)抗病位点的鉴定
  • 批准号:
    22780188
  • 财政年份:
    2010
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了